Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorUniversity Hospital Olomouc
About this trial
This study aims to develop accessible methods for the early detection of selected neuropathologies in drivers, focusing on multiple sclerosis and Parkinson's disease. The primary objective is to identify clinical tests that correlate with outcomes from the Vienna Test System (VTS), thereby enabling early diagnosis without the need for complex neurological or neuropsychological assessments. Findings could improve the effectiveness of routine driver medical check-ups and inform future modifications to Czech traffic law to enhance road safety.
Eligibility criteria
Qualifiers
Person after signing informed consent.
After meeting the valid diagnostic criteria for the given neurological diagnosis.
Possession of a valid driver's license and proof of active driving.
Age limit 18 - 85 years.
Disqualifiers
Proven diagnosis of dementia based on a current psychological examination (MMSE 24 points or less).
Diagnosis of a disease or condition that, according to Czech Law. No. 277/2004 Coll., on medical fitness to drive motor vehicles, as amended (especially Law No. 204/2025 Coll.), prevents or significantly limits the ability to drive a motor vehicle safely (e.g. dementia, epilepsy, severe disorders of consciousness).
Age less than 18 years.
Age more than 85 years.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsSponsors and collaborators
University Hospital Olomouc
Lead sponsor
Palacky University
Collaborator
Source ClinicalTrials.gov